| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Microbiology and Immunology
Medicine Downstate Medical Center, Brooklyn, New York, N.Y. 11203, U.S.A.
Department of Microbiology
Rutgers Medical School, Piscataway, New Jersey 08854, U.S.A.
Vaccinia virus-induced morphological lesions were studied in LLC-MK2, HeLa and L cells. In LLC-MK2 cells, cell rounding occurs within 30 to 60 min after infection with 300, 900 or 2700 particles/cell and the time of appearance of these changes is dependent on the multiplicity of infection (m.o.i.). When cycloheximide (300 µg/ml) is added to cultures at the time of infection, early cell rounding is prevented regardless of the m.o.i. However, cell rounding does occur when cycloheximide is removed, and its time of appearance and extent depends upon the time of removal of the compound and the m.o.i. Upon removal of cycloheximide at 1 or 2 h after infection early cell rounding occurs, and virus polypeptide synthesis is evident in cells infected at all three multiplicities. However, when the drug is removed at 4 h after infection, cell rounding and virus polypeptide synthesis occur only in cultures infected at 300 particles/cell. Early morphological changes are also prevented in HeLa and L cells infected at 300 particles/cell in the presence of cycloheximide. These changes occur only if the compound is removed up to 2 h after infection in HeLa cells and up to 40 min after infection in L cells. Early morphological lesions are not seen if the compound is removed at later times. The occurrence of early morphological changes in HeLa and L cells is also correlated with the synthesis of virus polypeptides. All cell types, when infected at 2700 particles/cell in the presence of cycloheximide, or inhibitors of RNA synthesis, display cell fusion. Thus, whereas early morphological changes require virus protein synthesis to become manifest, cell fusion occurs in the absence of virus RNA or protein synthesis and may be mediated by a component of the virion.
Present address: Plum Island Animal Disease Center, P.O. Box 848, Greenport, New York, U.S.A.
Received 28 June 1977;
accepted 5 December 1977.
This article has been cited by other articles:
|
|
 |
|
  E. Assarsson, J. A. Greenbaum, M. Sundstrom, L. Schaffer, J. A. Hammond, V. Pasquetto, C. Oseroff, R. C. Hendrickson, E. J. Lefkowitz, D. C. Tscharke, et al. Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes PNAS, February 12, 2008; 105(6): 2140 - 2145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Najera, C. E. Gomez, E. Domingo-Gil, M. M. Gherardi, and M. Esteban Cellular and Biochemical Differences between Two Attenuated Poxvirus Vaccine Candidates (MVA and NYVAC) and Role of the C7L Gene. J. Virol., June 1, 2006; 80(12): 6033 - 6047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Townsley, T. G. Senkevich, and B. Moss Vaccinia Virus A21 Virion Membrane Protein Is Required for Cell Entry and Fusion J. Virol., August 1, 2005; 79(15): 9458 - 9469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Senkevich, B. M. Ward, and B. Moss Vaccinia Virus Entry into Cells Is Dependent on a Virion Surface Protein Encoded by the A28L Gene J. Virol., March 1, 2004; 78(5): 2357 - 2366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pires de Miranda, P. C. Reading, D. C. Tscharke, B. J. Murphy, and G. L. Smith The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model J. Gen. Virol., September 1, 2003; 84(9): 2459 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Guerra, L. A. Lopez-Fernandez, A. Pascual-Montano, M. Munoz, K. Harshman, and M. Esteban Cellular Gene Expression Survey of Vaccinia Virus Infection of Human HeLa Cells J. Virol., June 1, 2003; 77(11): 6493 - 6506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Ramirez and L. J. Sigal Macrophages and Dendritic Cells Use the Cytosolic Pathway to Rapidly Cross-Present Antigen from Live, Vaccinia-Infected Cells J. Immunol., December 15, 2002; 169(12): 6733 - 6742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rey, S. Lee, and N.-H. Park Human Papillomavirus Type 16 E7 Oncoprotein Represses Transcription of Human Fibronectin J. Virol., May 15, 2000; 74(10): 4912 - 4918. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Sanderson and G. L. Smith Vaccinia Virus Induces Ca2+-Independent Cell-Matrix Adhesion during the Motile Phase of Infection J. Virol., December 1, 1998; 72(12): 9924 - 9933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Sanderson, M. Way, and G. L. Smith Virus-Induced Cell Motility J. Virol., February 1, 1998; 72(2): 1235 - 1243. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
